General Dermatology

In case you missed it, this week we had news about the FDA approvals of guselkumab for pediatric plaque psoriasis and PsA, along with remibrutinib for CSU, LEO Pharma's acquisition of spesolimab for GPP, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Explore insights from Renata Block DMSc, MMS, PA-C, and James Del Rosso, DO, on interpreting clinical trial data in dermatology for enhanced patient care and outcomes.

Dermatology Times is looking back on the top stories in dermatology from the month of September.

Dermatology Times is recapping our exclusive expert interviews from the month of September.

Miiskin integrates generative AI into dermatology, enhancing efficiency and patient access while reducing clinician workload and administrative tasks.

Learn more about the in-depth topics covered in the September 2025 print issue of Dermatology Times.

Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about upadacitinib's phase 3 efficacy in alopecia, APG777 as a potential breakthrough in AD, the latest conference insights, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Virginia Sybert, MD, emphasizes the importance of judicious genetic testing in pediatric dermatology, advocating for collaboration to enhance patient care.

Derm Dispatch host Renata Block, DMSc, MMS, PA-C, and Buchi Neita, MCMSc, PA-C, discuss how to revolutionize dermatology with lifestyle medicine, enhancing skin health and overall well-being.

Jorge Garcia-Zuazaga, MD, MBA, FAAD, FACMS, shares how Apex Skin’s multi-site model advances clinical trial access, diversity, and execution.

Explore cutting-edge insights from DERM 2025, focusing on innovative treatments and emerging research in dermatology for improved patient care.

The oral degrader produced biomarker reductions consistent with or superior to dupilumab, according to data presented at EADV 2025.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about the long-term safety of Amgen’s rocatinlimab for AD, the shared genetic backgrounds of cardiovascular diseases and psoriasis, the availability of LEO Pharma's delgocitinib cream, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Dermatologists and hairstylists unite to address scalp health, cultural practices, and patient care at the Science of Skin & Scalp Studio event.

Darker skin tones face higher risks of photosensitivity and thermal burns during dual-wavelength laser therapy, highlighting the need for tailored treatment approaches.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about Arcutis' sNDA for roflumilast in pediatric plaque psoriasis patients, Replimune's Type A meeting with the FDA on RP1, insights on deuruxolitinib for hair growth in alopecia, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Explore how dermatology-focused global medical missions can move beyond short-term “voluntourism” by fostering sustainable, collaborative partnerships that prioritize education, capacity building, and alignment with host country needs.